» Articles » PMID: 37111339

In Vitro and In Vivo Functional Viability, and Biocompatibility Evaluation of Bovine Serum Albumin-Ingrained Microemulsion: A Model Based on Sesame Oil As the Payload for Developing an Efficient Drug Delivery Platform

Overview
Publisher MDPI
Specialty Chemistry
Date 2023 Apr 28
PMID 37111339
Authors
Affiliations
Soon will be listed here.
Abstract

Combination of bovine serum albumin with microemulsions as constituting ingredient biopolymer has long been regarded an innovative method to address the surface functionalization and stability issues in the targeted payload deliveries, thereupon producing effectively modified microemulsions, which are superior in loading capacity, transitional and shelf-stability, as well as site-directed/site-preferred delivery, has become a favored option. The current study aimed to develop an efficient, suitable and functional microemulsion system encapsulating sesame oil (SO) as a model payload towards developing an efficient delivery platform. UV-VIS, FT-IR, and FE-SEM were used to characterize, and analyze the developed carrier. Physicochemical properties assessments of the microemulsion by dynamic light scattering size distributions, zeta-potential, and electron micrographic analyses were performed. The mechanical properties for rheological behavior were also studied. The HFF-2 cell line and hemolysis assays were conducted to ascertain the cell viability, and in vitro biocompatibility. The in vivo toxicity was determined based on a predicted median lethal dose (LD) model, wherein the liver enzymes' functions were also tested to assess and confirm the predicted toxicity.

Citing Articles

Liposome Nanocarriers Based on γ Oryzanol: Preparation, Characterization, and Assessment of Toxicity and Antioxidant Activity.

Jasim A, Albukhaty S, Sulaiman G, Al-Karagoly H, Jabir M, Abomughayedh A ACS Omega. 2024; 9(3):3554-3564.

PMID: 38284009 PMC: 10809378. DOI: 10.1021/acsomega.3c07339.


Exploring the Versatility of Microemulsions in Cutaneous Drug Delivery: Opportunities and Challenges.

Ait-Touchente Z, Zine N, Jaffrezic-Renault N, Errachid A, Lebaz N, Fessi H Nanomaterials (Basel). 2023; 13(10).

PMID: 37242104 PMC: 10222322. DOI: 10.3390/nano13101688.

References
1.
Solanki R, Rostamabadi H, Patel S, Jafari S . Anticancer nano-delivery systems based on bovine serum albumin nanoparticles: A critical review. Int J Biol Macromol. 2021; 193(Pt A):528-540. DOI: 10.1016/j.ijbiomac.2021.10.040. View

2.
Cantarovich M, Tzimas G, Barkun J, Deschenes M, Alpert E, Tchervenkov J . Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver-transplant patients with renal dysfunction. Transplantation. 2003; 76(1):98-102. DOI: 10.1097/01.TP.0000054367.57978.4C. View

3.
Schubert M, Muller-Goymann C . Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Eur J Pharm Biopharm. 2005; 61(1-2):77-86. DOI: 10.1016/j.ejpb.2005.03.006. View

4.
Chodari L, Dilsiz Aytemir M, Vahedi P, Alipour M, Zununi Vahed S, Hosseiniyan Khatibi S . Targeting Mitochondrial Biogenesis with Polyphenol Compounds. Oxid Med Cell Longev. 2021; 2021:4946711. PMC: 8289611. DOI: 10.1155/2021/4946711. View

5.
Hemlata , Gupta S, Tejavath K . ROS-Mediated Apoptosis Induced by BSA Nanospheres Encapsulated with Fruit Extract of in Various Human Cancer Cell Lines. ACS Omega. 2021; 6(15):10383-10395. PMC: 8153748. DOI: 10.1021/acsomega.1c00755. View